RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.
about
RLIP76, a non-ABC transporter, and drug resistance in epilepsy.Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerRLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancerRole of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76RLIP76: a versatile transporter and an emerging target for cancer therapy.Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancerGlutathione-conjugate transport by RLIP76 is required for clathrin-dependent endocytosis and chemical carcinogenesis.Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapseHsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76RLIP76: A novel glutathione-conjugate and multi-drug transporter.Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugatesRegression of prostate cancer xenografts by RLIP76 depletion.RLIP76 and Cancer.Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.RLIP76 Targeted Therapy for Kidney CancerRLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer.RLIP76: a target for kidney cancer therapy.Increased expression of cdc2 inhibits transport function of RLIP76 and promotes apoptosisDT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells.Non-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitors.P300 regulates the human RLIP76 promoter activity and gene expressionRlip depletion prevents spontaneous neoplasia in TP53 null mice.
P2860
Q24533543-1D089B4B-4903-4CE3-BADF-A2807FAA2F46Q28396304-EC74044C-1208-4503-BBF8-57EF431353A0Q28482104-B488178B-B7BC-4862-BD9E-BE0B2600E308Q30051796-D237510D-8966-4036-A6E6-3A16ADE5147AQ33867008-37236760-DA99-4B08-B66E-4A45A1579644Q34556062-E5B95775-8C32-4E5D-A25C-C40E9CE8ECFFQ34729940-77B7E00E-31ED-44F3-9997-198BE827E6D0Q34729947-36E0542C-A3AE-464E-A145-696DB4086D7EQ36129973-9AA6B285-B980-4043-B6BF-E09692A71F68Q36744205-7EF5F1FF-FDCA-4964-BE10-5D80062E8E98Q36982690-8A55E894-E972-40E8-8973-F278213FD4F9Q37146979-CEFFA712-FA4E-4E4D-B69C-621118F19A11Q37146994-387D889D-33EF-4A9A-8E70-0A55440DF24CQ37194622-F1B2B671-F654-4C5D-AD00-5430D1B022E6Q37217140-33830F78-D884-462D-B305-CDFC3FABC86AQ37368518-BAA7ACF4-8607-491E-A6FE-6301798E0532Q37741408-F2D7AE69-4DCD-4D24-9FBD-8658E4171527Q38749340-BC898364-A06F-4419-A6E0-7354BBA6CCBCQ39856444-7E02AF33-E957-4771-BA67-7EE54FF1C15FQ39859514-F97C8395-8B3E-4E21-95BA-353BD2FD2914Q41082765-ACE378A5-0AC8-4B11-99EB-FE4F02AF80CFQ41616227-E55FE5CF-B310-4206-985A-E4E6404E3898Q42051924-4F014030-24B2-49FF-9B38-DA90F54840D5Q52724571-76216AB6-FECB-4F15-B7A4-D2DFAF672CEB
P2860
RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.
@en
type
label
RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.
@en
prefLabel
RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.
@en
P2093
P1433
P1476
RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.
@en
P2093
Jyotsana Singhal
Sanjay Awasthi
Sharad S Singhal
Sushma Yadav
Yogesh C Awasthi
P304
P407
P577
2005-02-01T00:00:00Z